Tyler Cowen engages today’s deepest thinkers in wide-ranging explorations of their work, the world, and everything in between. New conversations every other Wednesday. Subscribe wherever you get your podcasts.
https://www.conversationswithtyler.com
episode 113: Noubar Afeyan on the Permission to Leap
“The world of innovation is very much one of toggling between survival and then thriving,” says Noubar Afeyan. Co-founder of Moderna and CEO of Flagship Pioneering, the biomedical innovator, philanthropist, and entrepreneur credits his successes to his “paranoid optimism” shaped by his experiences as an Armenian-American. Exceptional achievements like the rapid development of the COVID-19 vaccine, he believes, aren’t usually unpredictable but rather the result of systematic processes that include embracing unreasonable propositions and even unreasonable people.
He joined Tyler to discuss which aspect of entrepreneurship is hardest to teach, his predictions on the future of gene editing and CRISPR technology, why the pharmaceutical field can’t be winner takes all, why “basic research” is a poor term, the secret to Boston’s culture of innovation, the potential of plant biotech, why Montreal is (still) a special place to him, how his classical pianist mother influenced his musical tastes, his discussion-based approach to ethical dilemmas, how thinking future-backward shapes his approach to business and philanthropy, the blessing and curse of Lebanese optimism, the importance of creating a culture where people can say things that are wrong, what we can all learn by being an American by choice, and more.
Read a full transcript enhanced with helpful links, or watch the full video.
Recorded January 6th, 2021
Other ways to connect
- Follow us on Twitter and Instagram
- Follow Tyler on Twitter
- Follow Noubar on Twitter
- Email us: cowenconvos@mercatus.gmu.edu
- Subscribe at our newsletter page to have the latest Conversations with Tyler news sent straight to your inbox.